Bank of Montreal’s Aptose Biosciences, Inc. APTO Stock Holding History

Bank of Montreal’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-333	Closed	-$702K	–	5435
2020 Q4	$702K	Buy	+333	New	+$782K	﹤0.01%	2506

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of Montreal's APTO Position: Q4 2021 in Review

Bank of Montreal sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 24 shares — an estimated $30K sold.

Bank of Montreal first reported a position in APTO in Q1 2015 and held it in 27 quarters. The position peaked at $635K in Q1 2015. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

Bank of Montreal reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
Bank of Montreal sold 24 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $30K.
Bank of Montreal first reported a position in Aptose Biosciences, Inc. in Q1 2015 and held it in 27 quarters.
Bank of Montreal's Aptose Biosciences, Inc. position peaked at $635K in Q1 2015.
58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.